161 related articles for article (PubMed ID: 37999138)
21. Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.
Drake BF; Keane TE; Mosley CM; Adams SA; Elder KT; Modayil MV; Ureda JR; Hebert JR
J S C Med Assoc; 2006 Aug; 102(7):241-9. PubMed ID: 17319238
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer screening between low-income African-American and Caucasian men.
Fowke JH; Schlundt D; Signorello LB; Ukoli FA; Blot WJ
Urol Oncol; 2005; 23(5):333-40. PubMed ID: 16144667
[TBL] [Abstract][Full Text] [Related]
23. Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina.
Ellis SD; Blackard B; Carpenter WR; Mishel M; Chen RC; Godley PA; Mohler JL; Bensen JT
Cancer; 2013 Jun; 119(12):2282-90. PubMed ID: 23575751
[TBL] [Abstract][Full Text] [Related]
24. 'Race' and prostate cancer mortality in equal-access healthcare systems.
Graham-Steed T; Uchio E; Wells CK; Aslan M; Ko J; Concato J
Am J Med; 2013 Dec; 126(12):1084-8. PubMed ID: 24262722
[TBL] [Abstract][Full Text] [Related]
25. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
[TBL] [Abstract][Full Text] [Related]
26. Racial disparities in mortality for patients with prostate cancer after radical prostatectomy.
Wen W; Luckenbaugh AN; Bayley CE; Penson DF; Shu XO
Cancer; 2021 May; 127(9):1517-1528. PubMed ID: 32895938
[TBL] [Abstract][Full Text] [Related]
27. Racial disparities in prostate cancer among black men: epidemiology and outcomes.
Chowdhury-Paulino IM; Ericsson C; Vince R; Spratt DE; George DJ; Mucci LA
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):397-402. PubMed ID: 34475523
[TBL] [Abstract][Full Text] [Related]
28. Race, Decisional Regret and Prostate Cancer Beliefs: Identifying Targets to Reduce Racial Disparities in Prostate Cancer.
DeWitt-Foy ME; Gam K; Modlin C; Kim SP; Abouassaly R
J Urol; 2021 Feb; 205(2):426-433. PubMed ID: 33226309
[TBL] [Abstract][Full Text] [Related]
29. Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer.
Esdaille AR; Ibilibor C; Holmes A; Palmer NR; Murphy AB
Urology; 2022 May; 163():90-98. PubMed ID: 34582887
[TBL] [Abstract][Full Text] [Related]
30. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O
J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182
[TBL] [Abstract][Full Text] [Related]
31. Racial Disparities in Prostate Specific Antigen Screening and Referral to Urology in a Large, Integrated Health Care System: A Retrospective Cohort Study.
Lu CD; Adeyemi O; Anderson WE; Hetherington TC; Slawson DC; Tapp H; Eaton TA; Burgess EF; Grigg CM; Zhu JZ; Gaston KE; Riggs SB; Clark PE; Taylor YJ; Kearns JT
J Urol; 2021 Aug; 206(2):270-278. PubMed ID: 33793294
[TBL] [Abstract][Full Text] [Related]
32. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
[TBL] [Abstract][Full Text] [Related]
33. Income inequality and treatment of African American men with high-risk prostate cancer.
Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
[TBL] [Abstract][Full Text] [Related]
34. Racial disparities in prostate cancer survival in a screened population: Reality versus artifact.
Kaur D; Ulloa-Pérez E; Gulati R; Etzioni R
Cancer; 2018 Apr; 124(8):1752-1759. PubMed ID: 29370459
[TBL] [Abstract][Full Text] [Related]
35. Racial Disparity in Response to Prostate Cancer Systemic Therapies.
Bitting RL; Goodman M; George DJ
Curr Oncol Rep; 2020 Jul; 22(9):96. PubMed ID: 32700096
[TBL] [Abstract][Full Text] [Related]
36. Racial differences in the PSA bounce in predicting prostate cancer outcomes after brachytherapy: Evidence from the Department of Veterans Affairs.
Slade AN; Dahman B; Chang MG
Brachytherapy; 2020; 19(1):6-12. PubMed ID: 31611160
[TBL] [Abstract][Full Text] [Related]
37. Patient perspectives of prostate cancer screening vary by race following 2018 guideline changes.
Riviere P; Kalavacherla S; Banegas MP; Javier-Desloges J; Martinez ME; Garraway IP; Murphy JD; Rose BS
Cancer; 2023 Jan; 129(1):82-88. PubMed ID: 36345568
[TBL] [Abstract][Full Text] [Related]
38. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
[TBL] [Abstract][Full Text] [Related]
39. Prostate Cancer: Community Education and Disparities in Diagnosis and Treatment.
Carthon B; Sibold HC; Blee S; D Pentz R
Oncologist; 2021 Jul; 26(7):537-548. PubMed ID: 33683758
[TBL] [Abstract][Full Text] [Related]
40. Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics.
Lowder D; Rizwan K; McColl C; Paparella A; Ittmann M; Mitsiades N; Kaochar S
Cancer Lett; 2022 Apr; 531():71-82. PubMed ID: 35122875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
